Evaluation of the “Multivariable Psoriatic Arthritis Risk Estimation Tool” in a Cohort of Patients with Psoriasis: Preliminary Results of a Prospective Observational Study
Abstract Introduction An intriguing aspect that emerged in recent years is the transition phase from psoriasis (PsO) to psoriatic arthritis (PsA). The PRESTO instrument allows estimating a patient’s risk of developing PsA based on a few clinical items. The aim of this study was to apply and evaluate...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2024-12-01
|
| Series: | Rheumatology and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s40744-024-00729-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832585364587413504 |
|---|---|
| author | Ennio Lubrano Filomena Mandato Marcella Antenucci Fabio Massimo Perrotta |
| author_facet | Ennio Lubrano Filomena Mandato Marcella Antenucci Fabio Massimo Perrotta |
| author_sort | Ennio Lubrano |
| collection | DOAJ |
| description | Abstract Introduction An intriguing aspect that emerged in recent years is the transition phase from psoriasis (PsO) to psoriatic arthritis (PsA). The PRESTO instrument allows estimating a patient’s risk of developing PsA based on a few clinical items. The aim of this study was to apply and evaluate the performance of the PRESTO tool in a cohort of patients with PsO. Methods Consecutive patients with PsO were enrolled. Dermatological and rheumatological assessment was carried out in order to evaluate clinical features of PsO, to exclude the diagnosis of PsA, and to administer the PRESTO tool. Results Between January 1, 2024 and April 1, 2024, 100 patients were assessed. Eight-four patients found the questionnaire to be very useful and easy. The estimated risk (median/IQR) of 1-year progression to PsA found in our group was 2.45% at 1 year (1.1–4). Conclusions The PRESTO instrument was feasible and well accepted by patients. The 1-year risk assessed by PRESTO tools is consistent with other reports in the literature. |
| format | Article |
| id | doaj-art-843287b0e0db4624b15f639665c3d786 |
| institution | Kabale University |
| issn | 2198-6576 2198-6584 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Adis, Springer Healthcare |
| record_format | Article |
| series | Rheumatology and Therapy |
| spelling | doaj-art-843287b0e0db4624b15f639665c3d7862025-01-26T12:52:05ZengAdis, Springer HealthcareRheumatology and Therapy2198-65762198-65842024-12-0112120320910.1007/s40744-024-00729-3Evaluation of the “Multivariable Psoriatic Arthritis Risk Estimation Tool” in a Cohort of Patients with Psoriasis: Preliminary Results of a Prospective Observational StudyEnnio Lubrano0Filomena Mandato1Marcella Antenucci2Fabio Massimo Perrotta3Academic Rheumatology Unit and MoRhe Project, Dipartimento di Medicina e Scienze della Salute “Vincenzo Tiberio”, Università degli Studi del MoliseDermatology Unit, Azienda Sanitaria Regionale del MoliseAcademic Rheumatology Unit and MoRhe Project, Dipartimento di Medicina e Scienze della Salute “Vincenzo Tiberio”, Università degli Studi del MoliseAcademic Rheumatology Unit and MoRhe Project, Dipartimento di Medicina e Scienze della Salute “Vincenzo Tiberio”, Università degli Studi del MoliseAbstract Introduction An intriguing aspect that emerged in recent years is the transition phase from psoriasis (PsO) to psoriatic arthritis (PsA). The PRESTO instrument allows estimating a patient’s risk of developing PsA based on a few clinical items. The aim of this study was to apply and evaluate the performance of the PRESTO tool in a cohort of patients with PsO. Methods Consecutive patients with PsO were enrolled. Dermatological and rheumatological assessment was carried out in order to evaluate clinical features of PsO, to exclude the diagnosis of PsA, and to administer the PRESTO tool. Results Between January 1, 2024 and April 1, 2024, 100 patients were assessed. Eight-four patients found the questionnaire to be very useful and easy. The estimated risk (median/IQR) of 1-year progression to PsA found in our group was 2.45% at 1 year (1.1–4). Conclusions The PRESTO instrument was feasible and well accepted by patients. The 1-year risk assessed by PRESTO tools is consistent with other reports in the literature.https://doi.org/10.1007/s40744-024-00729-3Psoriatic arthritisPsoriasisPRESTOTransition phaseRisk |
| spellingShingle | Ennio Lubrano Filomena Mandato Marcella Antenucci Fabio Massimo Perrotta Evaluation of the “Multivariable Psoriatic Arthritis Risk Estimation Tool” in a Cohort of Patients with Psoriasis: Preliminary Results of a Prospective Observational Study Rheumatology and Therapy Psoriatic arthritis Psoriasis PRESTO Transition phase Risk |
| title | Evaluation of the “Multivariable Psoriatic Arthritis Risk Estimation Tool” in a Cohort of Patients with Psoriasis: Preliminary Results of a Prospective Observational Study |
| title_full | Evaluation of the “Multivariable Psoriatic Arthritis Risk Estimation Tool” in a Cohort of Patients with Psoriasis: Preliminary Results of a Prospective Observational Study |
| title_fullStr | Evaluation of the “Multivariable Psoriatic Arthritis Risk Estimation Tool” in a Cohort of Patients with Psoriasis: Preliminary Results of a Prospective Observational Study |
| title_full_unstemmed | Evaluation of the “Multivariable Psoriatic Arthritis Risk Estimation Tool” in a Cohort of Patients with Psoriasis: Preliminary Results of a Prospective Observational Study |
| title_short | Evaluation of the “Multivariable Psoriatic Arthritis Risk Estimation Tool” in a Cohort of Patients with Psoriasis: Preliminary Results of a Prospective Observational Study |
| title_sort | evaluation of the multivariable psoriatic arthritis risk estimation tool in a cohort of patients with psoriasis preliminary results of a prospective observational study |
| topic | Psoriatic arthritis Psoriasis PRESTO Transition phase Risk |
| url | https://doi.org/10.1007/s40744-024-00729-3 |
| work_keys_str_mv | AT enniolubrano evaluationofthemultivariablepsoriaticarthritisriskestimationtoolinacohortofpatientswithpsoriasispreliminaryresultsofaprospectiveobservationalstudy AT filomenamandato evaluationofthemultivariablepsoriaticarthritisriskestimationtoolinacohortofpatientswithpsoriasispreliminaryresultsofaprospectiveobservationalstudy AT marcellaantenucci evaluationofthemultivariablepsoriaticarthritisriskestimationtoolinacohortofpatientswithpsoriasispreliminaryresultsofaprospectiveobservationalstudy AT fabiomassimoperrotta evaluationofthemultivariablepsoriaticarthritisriskestimationtoolinacohortofpatientswithpsoriasispreliminaryresultsofaprospectiveobservationalstudy |